Citation: | HAN Lina, LI Yangyang, BAI Xiaomin. Predictive value of bronchial diastolic response test in adult patients with chronic cough suspected as cough variant asthma[J]. Journal of Clinical Medicine in Practice, 2024, 28(9): 95-98. DOI: 10.7619/jcmp.20232522 |
To explore the value of bronchial diastolic response (BDR) test in predicting the cough variant asthma (CVA) in patients with chronic cough or negative result of BDR test.
A total of 140 patients with chronic cough and negative result of BDR test were selected and treated with inhaled corticosteroids (ICS) and long-acting β2-agonists for 4 weeks, and their lung functions were detected before and after treatment. Receiver operating characteristic (ROC) curve was used to evaluate the predictive values of the forced expiratory volume in the first second as a percentage of predicted value (FEV1 %), exhaled nitric oxide (FeNO), forced expiratory flow at 25 % to 75 %(FEF25 % to 75 %)and forced expiratory flow rate in 25 % to 75 % (FEF %25 % to 75 %) alone or their combined diagnosis.
After treatment, there were 98 cases diagnosed as negative for CVA and 42 cases diagnosed as positive for CVA. In combination of evaluation indexes, the top three combinations for CVA diagnosis were FEF %25 % to 75 %+△FEV1 %, FEF25 % to 75 % +FeNO, and △FEV1 +△FEV1 %. Venn diagram of the combined prediction showed that there was an overlap in CVA positive diagnostic patients with FeNO ≥ 41.50×10-9 mol/L, △FEV1 % ≥ 5.90 %, and FEF %25 % to 75 % ≤ 61.99 %.
After treatment, patient's showing FeNO ≥ 41.50×10-9 mol/L, △FEV1 % ≥ 5.90 % and FEF %25 % to 75 % ≤ 61.99 % can be used to predict CVA and the response to anti-asthma treatment.
[1] |
赖克方. 慢性咳嗽[M]. 2版. 北京: 人民卫生出版社, 2019: 232-236.
|
[2] |
LAI K F, CHEN R C, LIN J T, et al. A prospective, multicenter survey on causes of chronic cough in China[J]. Chest, 2013, 143(3): 613-620. doi: 10.1378/chest.12-0441
|
[3] |
ZHONG N S, LIN J T, ZHENG J P, et al. Uncontrolled asthma and its risk factors in adult Chinese asthma patients[J]. Ther Adv Respir Dis, 2016, 10(6): 507-517. doi: 10.1177/1753465816663978
|
[4] |
中华医学会呼吸病学分会哮喘学组. 支气管哮喘防治指南(2020年版)[J]. 中华结核和呼吸杂志, 2020, 43(12): 1023-1048. doi: 10.3760/cma.j.cn112147-20200618-00721
|
[5] |
焦风伟, 侯安纳, 张黎明. 行气道激发试验检查哮喘及非哮喘患者临床分析[J]. 临床肺科杂志, 2022, 27(10): 1509-1513. doi: 10.3969/j.issn.1009-6663.2022.10.012
|
[6] |
冯连彩. COPD和哮喘患者支气管舒张实验用力肺活量和呼气容积的变化[J]. 临床肺科杂志, 2012, 17(4): 626-627. doi: 10.3969/j.issn.1009-6663.2012.04.020
|
[7] |
朱丽涛, 牟艳. 支气管激发试验和舒张试验在哮喘患者中的应用价值[J]. 海南医学, 2017, 28(6): 907-909. doi: 10.3969/j.issn.1003-6350.2017.06.016
|
[8] |
焦蕊, 庞立健, 吕晓东. 基于网络药理学探讨三拗汤治疗咳嗽变异型哮喘的作用机制[J]. 中华全科医学, 2021, 19(7): 1218-1223. https://www.cnki.com.cn/Article/CJFDTOTAL-SYQY202107039.htm
|
[9] |
谢仁炜, 王朝昕, 李云霞, 等. 区域医疗中心咳嗽患者临床特征及就诊流向的大数据挖掘分析[J]. 中华全科医学, 2022, 20(12): 2143-2146. https://www.cnki.com.cn/Article/CJFDTOTAL-SYQY202212037.htm
|
[10] |
席寅, 赖克方, 陈如冲, 等. 咳嗽变异性哮喘的临床特征及其与典型哮喘的关系[J]. 中华哮喘杂志: 电子版, 2011, 5(3): 150-155. doi: 10.3969/j.issn.1674-3911.2011.03.001
|
[11] |
谭伟, 杨贵丽, 黄招兰. 从全科医学的视角解读中国《咳嗽基层诊疗指南(2018年)》[J]. 中国全科医学, 2019, 22(33): 4035-4040. doi: 10.12114/j.issn.1007-9572.2019.00.502
|
[12] |
于成盼, 赵云, 王婷. 咳嗽变异性哮喘患者血清LDH水平与气道炎症指标的相关性及其在预后评估中的价值[J]. 检验医学与临床, 2022, 19(12): 1671-1674. doi: 10.3969/j.issn.1672-9455.2022.12.023
|
[13] |
闫利霞. 咳嗽变异性哮喘患儿血清25羟基维生素D3、免疫球蛋白E、血清淀粉样蛋白A水平与预后的相关性[J]. 中国临床医生杂志, 2020, 48(9): 1102-1104. doi: 10.3969/j.issn.2095-8552.2020.09.034
|
[14] |
侯俊荣. 布地奈德联和孟鲁司特钠治疗咳嗽变异性哮喘对肺功能指标与免疫球蛋白E和肿瘤坏死因子-α的影响[J]. 中国临床医生杂志, 2019, 47(5): 535-538. doi: 10.3969/j.issn.2095-8552.2019.05.011
|
[15] |
FUSSBROICH D, COLAS R A, EICKMEIER O, et al. A combination of LCPUFA ameliorates airway inflammation in asthmatic mice by promoting pro-resolving effects and reducing adverse effects of EPA[J]. Mucosal Immunol, 2020, 13(3): 481-492. doi: 10.1038/s41385-019-0245-2
|
[16] |
陈婷婷, 易桂生. 咳嗽变异性哮喘病理机制及造模方法的研究进展[J]. 实验动物科学, 2021, 38(2): 74-78. doi: 10.3969/j.issn.1006-6179.2021.02.014
|
[17] |
PRAKASH Y S, HALAYKO A J, GOSENS R, et al. An official American thoracic society research statement: current challenges facing research and therapeutic advances in airway remodeling[J]. Am J Respir Crit Care Med, 2017, 195(2): e4-e19. doi: 10.1164/rccm.201611-2248ST
|
[18] |
刘亚林, 谷峰. 孟鲁司特钠联合氯雷他定对咳嗽变异性哮喘患儿血清和诱导痰炎性介质的影响[J]. 检验医学与临床, 2019, 16(8): 1053-1056. doi: 10.3969/j.issn.1672-9455.2019.08.013
|
[19] |
《慢性阻塞性肺疾病诊治指南(2021年修订版)》诊断要点[J]. 实用心脑肺血管病杂志, 2021, 29(6): 134-134.
|
[20] |
李新玲, 朱颀峰, 孙爽, 等. 支气管哮喘患者血清MBL、IgE及FeNO的临床价值[J]. 中国老年学杂志, 2022, 42(7): 1620-1623. doi: 10.3969/j.issn.1005-9202.2022.07.026
|
[21] |
别柏林, 李安琪, 楚荷莹. FeNO联合血清SDF-1水平对支气管哮喘患者气道高反应的预测价值[J]. 临床肺科杂志, 2021, 26(10): 1506-1510. doi: 10.3969/j.issn.1009-6663.2021.10.011
|
[22] |
康恒, 李迅, 文华, 等. COPD患者外周血淋巴细胞计数及血清CRP PCT变化与疾病严重程度的关系[J]. 河北医学, 2023, 29(8): 1287-1292. doi: 10.3969/j.issn.1006-6233.2023.08.011
|